The aim of the current study was to determine how carriers of a recessive gene, which confers no risk to their own health, perceive their health, relative to noncarriers. Perceptions of health in three groups were compared: those screened and found to carry the gene for TaySachs disease, those screened and not found to carry the gene for Tay-Sachs disease, and a community based sample who, it was presumed, had not undergone screening. The groups did not differ in their perceptions of their current health or their past health. Carriers, however, viewed their future health with less optimism than the other two groups. The causes and consequences of this altered perception need to be explored in future studies. With the advent of population based screening for cystic fibrosis carrier status, these results highlight the importance of assessing in detail people's experiences of screening before the introduction of any mass genetic screening programmes.
In a more recent study, noncarriers of sickle cell trait perceived carriers as less happy, less healthy, and less active than did carriers. 5 Providing information about genetic make up may also change how people view themselves, in particular their health. This may be so for both carriers and non-carriers, but the effects are likely to be more marked for carriers. For example, 43% of parents of children found to be sickle cell carriers thought of their children as having a disease, with 66% of these parents thinking that their children needed dietary supplements to stay healthy.6 Sickle cell trait is not normally associated with clinical problems, but very occasionally it can manifest under conditions of severe hypoxic stress. It is unclear therefore whether negative attitudes towards carriers arise from this medical concern, or whether it reflects a more general prejudice against carriers of a genetic disease.
So far, there have been no studies of whether undergoing genetic screening alters how people view their health. There is some evidence from other health screening programmes that undergoing screening can undermine people's view of their health. For example, on occasions, undergoing screening has served to reassure people falsely about their health7; on other occasions it has inappropriately alarmed even those with a negative result. 8 The aim of the current study is to determine how carriers of a recessive gene, which confers no risk to their own health, perceive their health, relative to non-carriers.
Subjects
The subjects comprised three groups who had been screened for Tay-Sachs disease carrier status. One group of 50 subjects had been screened opportunistically 16 months earlier, when they attended a cultural exhibition for the Jewish community, and received a negative result. A further 50 people had received a negative result 16 months earlier, after attending a designated screening event in a local synagogue after extensive community advertising. The third group of 43 people had been screened over the last three years and found to be carriers for Tay-Sachs disease. This group included relatives, both Jewish and non-Jewish, of previously affected children (n = 8), and previously identified carriers for Tay-Sachs disease (n = 8), as well as persons identified by routine screening (n = 27). Thus this carrier group is drawn from a more heterogeneous source than the non-carriers. Twenty-seven of the carriers (63%) and 55 of the non-carriers (55%) responded to the questionnaire. The mean age of the non-carriers was 29 years (SD 7 2) and for the carriers it was 39-5 (SD 14-0). Responses (%) of carriers (n = 27), non-carriers (n = 55), and controls (n = 52) to each of the five questions assessing perceived health. 
Discussion
The results of this study suggest that learning that one is a carrier of a gene for a recessive genetic disorder changes people's views about their future health. This may be because these carriers (erroneously) consider that their future health will be jeopardised by the presence of an abnormal gene. In a study of over 1000 people attending for Tay-Sachs disease screening in the USA, 45% stated that it would matter a great deal to them if they were found to be carriers.9 McQueen9 was surprised at this finding stating that "Knowing the recessive character of the disease, one would assume that being a carrier would not matter so highly, for it is true that most individuals carry many recessive traits any one of which might be lethal in combination with a spouse who is a carrier of the same trait" (pl33). In an eight year follow up of those found to be carriers in a Tay-Sachs disease screening programme in Canada, 19% of carriers reported feeling some anxiety about this. 10 Measuring people's knowledge and beliefs about carrier status in future studies would shed more light on why being a carrier matters so much. At the root of many of the problems encountered by those participating in various screening programmes is a poor understanding of the tests they have undergone."' This is likely to be a particular problem for those undergoing genetic screening, given the generally poor level of scientific understanding in the general population.'2'3 If this explanation were true, then providing more information before and after screening to carriers may prevent this reduced optimism about the future.
An alternative explanation for the findings in the current study is that receipt of one piece of bad news about one's health (that is, learning that one is a carrier) reduces the general tendency for people to be optimistic when considering their chances of becoming ill or experiencing any misfortune. ' 19 The sample in this study was small and is not representative of the general population. Those who underwent screening differed from the comparison group in at least two respects: ethnic background and the fact that they had undergone a genetic screening test. Not all of the carriers were from the same sample as those who received a negative test result. It is possible that they may have differed in ways other than carrier status (such as a family history of the disease) which may have accounted for the differences observed between the groups. Future studies using larger and more representative groups are needed to determine the generalisability of the results.
Bearing in mind these limitations, the results of this pilot study suggest that learning one is a carrier for a genetic disease can have subtle, unintended effects upon a person's selfperception. With the advent of population based screening for cystic fibrosis carrier status, and in the near future other genetic diseases, these results highlight the importance of assessing in detail people's experiences of undergoing screening before the introduction of any mass screening programmes. Only in this way will we know the full implications of conducting genetic screening, a prerequisite to determining whether the benefits of population based screening will outweigh the harm.
